Do elevated urinary organic acids reflect microbial overgrowth and increased liver detoxification demand?

Intestinal dysbiosis and microbial overgrowth can generate a significant systemic load of organic acids, which serve as crucial urinary biomarkers and directly impact systemic metabolic pathways.

Clinical evidence of dysbiosis

• Fungal and Bacterial Markers: Elevated urinary D-arabinitol is a validated marker for Candida overgrowth, with high D-arabinitol/L-arabinitol (DA/LA) ratios indicating mucosal yeast colonization or invasive candidiasis.
• Fermentation Profiles: Citramalic acid, 3,4-dihydroxyphenylpropionic acid (DHPPA), phenylacetic acid, 4-hydroxyphenylacetic acid, and benzoic acid reflect bacterial fermentation of dietary polyphenols and aromatic amino acids. These are associated with dysbiosis involving taxa such as Clostridium, Bifidobacterium, and Propionibacterium.

Mechanistic explanations of hepatic load

• Metabolite Influx: Once absorbed from the gastrointestinal tract, aromatic carboxylic acids like benzoic and phenylacetic acids are transported directly to the liver, increasing hepatic clearance demands.
• Enzymatic Pathways: Hepatic detoxification of these compounds relies on ATP-dependent mitochondrial conjugation. Benzoic acid is activated to benzoyl-CoA and conjugated with glycine via the enzyme glycine N-acyltransferase (GLYAT) to form hippuric acid. Phenylacetic acid is similarly metabolized to phenylacetylglycine.
• Resource Depletion: Because GLYAT-mediated conjugation is capacity-limited, a continuous or excessive influx of these microbial metabolites can deplete hepatic glycine and coenzyme A (CoA) pools, saturating detoxification pathways and increasing metabolic strain on the liver.

Bottom line

• Elevated urinary levels of these organic acids indicate gut dysbiosis and yeast overgrowth, generating a systemic metabolite load that consumes critical hepatic glycine, ATP, and coenzyme A pools to increase overall detoxification demand.